Page last updated: 2024-08-21

perfluorobutane and Liver Steatosis

perfluorobutane has been researched along with Liver Steatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bijland, S; Butenhoff, JL; Chang, SC; Ehresman, DJ; Havekes, LM; Maas, AC; Pieterman, EJ; Princen, HM; Rensen, PC; van der Hoorn, JW; van Erk, MJ; Willems van Dijk, K	1

Other Studies

1 other study(ies) available for perfluorobutane and Liver Steatosis

Article	Year
Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE3-Leiden CETP mice. Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 123, Issue:1* Topics: Alkanesulfonic Acids; Animals; Cholesterol Ester Transfer Proteins; Fatty Liver; Fluorocarbons; Humans; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Quantitative Structure-Activity Relationship; Sulfonic Acids; Surface-Active Agents	2011

Article

Year

Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice.

Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 123, Issue:1

Topics: Alkanesulfonic Acids; Animals; Cholesterol Ester Transfer Proteins; Fatty Liver; Fluorocarbons; Humans; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Quantitative Structure-Activity Relationship; Sulfonic Acids; Surface-Active Agents

2011